Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1941 2
1942 3
1946 1
1953 2
1954 1
1956 1
1957 1
1958 1
1959 2
1960 3
1961 4
1962 4
1963 11
1964 10
1965 8
1966 9
1967 12
1968 11
1969 22
1970 18
1971 23
1972 27
1973 24
1974 43
1975 150
1976 152
1977 166
1978 185
1979 235
1980 245
1981 234
1982 261
1983 255
1984 228
1985 220
1986 186
1987 175
1988 166
1989 200
1990 174
1991 142
1992 153
1993 184
1994 129
1995 131
1996 144
1997 143
1998 141
1999 140
2000 144
2001 150
2002 141
2003 136
2004 151
2005 144
2006 193
2007 197
2008 195
2009 191
2010 228
2011 238
2012 267
2013 269
2014 267
2015 247
2016 270
2017 246
2018 289
2019 254
2020 111
Text availability
Article attribute
Article type
Publication date

Search Results

8,634 results
Results by year
Filters applied: . Clear all
Page 1
Models of the complement C1 complex.
Mortensen SA, Sander B, Jensen RK, Pedersen JS, Golas MM, Thiel S, Andersen GR. Mortensen SA, et al. Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):E3866. doi: 10.1073/pnas.1803577115. Epub 2018 Apr 13. Proc Natl Acad Sci U S A. 2018. PMID: 29654144 Free PMC article. No abstract available.
Inhibition of Immune Complex Complement Activation and Neutrophil Extracellular Trap Formation by Peptide Inhibitor of Complement C1.
Hair PS, Enos AI, Krishna NK, Cunnion KM. Hair PS, et al. Front Immunol. 2018 Mar 26;9:558. doi: 10.3389/fimmu.2018.00558. eCollection 2018. Front Immunol. 2018. PMID: 29632531 Free PMC article.
Here, we report in vitro testing of peptide inhibitor of complement C1 (PIC1) in assays of immune complex-mediated complement activation in human sera and assays for NET formation by human neutrophils. The lead PIC1 derivative, PA-dPEG24, was able to dose-dep …
Here, we report in vitro testing of peptide inhibitor of complement C1 (PIC1) in assays of immune complex-mediated compleme
Structure of the C1 complex of complement.
Arlaud GJ, Gaboriaud C, Ling WL, Thielens NM. Arlaud GJ, et al. Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):E5766-E5767. doi: 10.1073/pnas.1703977114. Epub 2017 Jul 12. Proc Natl Acad Sci U S A. 2017. PMID: 28701384 Free PMC article. No abstract available.
Complement Component C1q: Historical Perspective of a Functionally Versatile, and Structurally Unusual, Serum Protein.
Reid KBM. Reid KBM. Front Immunol. 2018 Apr 10;9:764. doi: 10.3389/fimmu.2018.00764. eCollection 2018. Front Immunol. 2018. PMID: 29692784 Free PMC article. Review.
Complement component C1q plays an important recognition role in adaptive, and innate, immunity through its ability to interact, via its six globular head regions, with both immunoglobulin and non-immunoglobulin activators of the complement system, and also in the cl
Complement component C1q plays an important recognition role in adaptive, and innate, immunity through its ability to interact, via i
Mechanisms of complement activation and effects of C1-inhibitor on the meconium-induced inflammatory reaction in human cord blood.
Salvesen B, Nielsen EW, Harboe M, Saugstad OD, Mollnes TE. Salvesen B, et al. Mol Immunol. 2009 Feb;46(4):688-94. doi: 10.1016/j.molimm.2008.09.001. Epub 2008 Oct 31. Mol Immunol. 2009. PMID: 18950866
Meconium activates the complement system and meconium-induced cytokine formation is differentially mediated by complement and CD14. C1-inhibitor (C1-INH) regulates complement and contact-system activation mainly by protease inhibition, but may r …
Meconium activates the complement system and meconium-induced cytokine formation is differentially mediated by complement and …
Reply to Mortensen et al.: The zymogen form of complement component C1.
Almitairi JOM, Venkatraman Girija U, Furze CM, Simpson-Gray X, Badakshi F, Marshall JE, Schwaeble WJ, Mitchell DA, Moody PCE, Wallis R. Almitairi JOM, et al. Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):E3867-E3868. doi: 10.1073/pnas.1804497115. Epub 2018 Apr 13. Proc Natl Acad Sci U S A. 2018. PMID: 29654143 Free PMC article. No abstract available.
The first component of human complement (C1): activation and control.
Ziccardi RJ. Ziccardi RJ. Springer Semin Immunopathol. 1983;6(2-3):213-30. doi: 10.1007/BF00205874. Springer Semin Immunopathol. 1983. PMID: 6314572 Review.
The first component of human complement (C1) is a 750 000 dalton glycoprotein that requires calcium or other specific metal ions to maintain its native structure and function. ...Finally, recent studies indicate that C1 may have other important biologic funct …
The first component of human complement (C1) is a 750 000 dalton glycoprotein that requires calcium or other specific metal io …
The first component of human complement--C1.
Sim RB. Sim RB. Methods Enzymol. 1981;80 Pt C:6-16. doi: 10.1016/s0076-6879(81)80004-3. Methods Enzymol. 1981. PMID: 7043203 Review. No abstract available.
Structure and activation of the C1 complex of complement: unraveling the puzzle.
Gaboriaud C, Thielens NM, Gregory LA, Rossi V, Fontecilla-Camps JC, Arlaud GJ. Gaboriaud C, et al. Trends Immunol. 2004 Jul;25(7):368-73. doi: 10.1016/j.it.2004.04.008. Trends Immunol. 2004. PMID: 15207504 Review. No abstract available.
Structural biology of the C1 complex of complement unveils the mechanisms of its activation and proteolytic activity.
Arlaud GJ, Gaboriaud C, Thielens NM, Budayova-Spano M, Rossi V, Fontecilla-Camps JC. Arlaud GJ, et al. Mol Immunol. 2002 Nov;39(7-8):383-94. doi: 10.1016/s0161-5890(02)00143-8. Mol Immunol. 2002. PMID: 12413689 Review.
C1 is the multimolecular protease that triggers activation of the classical pathway of complement, a major element of antimicrobial host defense also involved in immune tolerance and various pathologies. ...Early studies mainly based on biochemical analysis and elec
C1 is the multimolecular protease that triggers activation of the classical pathway of complement, a major element of antimicr
8,634 results
Jump to page
Feedback